179 related articles for article (PubMed ID: 28468826)
1. Neuropilin-1 mediates neutrophil elastase uptake and cross-presentation in breast cancer cells.
Kerros C; Tripathi SC; Zha D; Mehrens JM; Sergeeva A; Philips AV; Qiao N; Peters HL; Katayama H; Sukhumalchandra P; Ruisaard KE; Perakis AA; St John LS; Lu S; Mittendorf EA; Clise-Dwyer K; Herrmann AC; Alatrash G; Toniatti C; Hanash SM; Ma Q; Molldrem JJ
J Biol Chem; 2017 Jun; 292(24):10295-10305. PubMed ID: 28468826
[TBL] [Abstract][Full Text] [Related]
2. Broad cross-presentation of the hematopoietically derived PR1 antigen on solid tumors leads to susceptibility to PR1-targeted immunotherapy.
Alatrash G; Mittendorf EA; Sergeeva A; Sukhumalchandra P; Qiao N; Zhang M; St John LS; Ruisaard K; Haugen CE; Al-Atrache Z; Jakher H; Philips AV; Ding X; Chen JQ; Wu Y; Patenia RS; Bernatchez C; Vence LM; Radvanyi LG; Hwu P; Clise-Dwyer K; Ma Q; Lu S; Molldrem JJ
J Immunol; 2012 Dec; 189(11):5476-84. PubMed ID: 23105141
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil elastase enhances antigen presentation by upregulating human leukocyte antigen class I expression on tumor cells.
Chawla A; Alatrash G; Philips AV; Qiao N; Sukhumalchandra P; Kerros C; Diaconu I; Gall V; Neal S; Peters HL; Clise-Dwyer K; Molldrem JJ; Mittendorf EA
Cancer Immunol Immunother; 2016 Jun; 65(6):741-51. PubMed ID: 27129972
[TBL] [Abstract][Full Text] [Related]
4. Targeting the Leukemia Antigen PR1 with Immunotherapy for the Treatment of Multiple Myeloma.
Alatrash G; Perakis AA; Kerros C; Peters HL; Sukhumalchandra P; Zhang M; Jakher H; Zope M; Patenia R; Sergeeva A; Yi S; Young KH; Philips AV; Cernosek AM; Garber HR; Qiao N; Weng J; St John LS; Lu S; Clise-Dwyer K; Mittendorf EA; Ma Q; Molldrem JJ
Clin Cancer Res; 2018 Jul; 24(14):3386-3396. PubMed ID: 29661776
[No Abstract] [Full Text] [Related]
5. The role of antigen cross-presentation from leukemia blasts on immunity to the leukemia-associated antigen PR1.
Alatrash G; Ono Y; Sergeeva A; Sukhumalchandra P; Zhang M; St John LS; Yang TH; Ruisaard K; Armistead PM; Mittendorf EA; He H; Qiao N; Rodriguez-Cruz T; Liang S; Clise-Dwyer K; Wieder ED; Lizee G; Lu S; Molldrem JJ
J Immunother; 2012 May; 35(4):309-20. PubMed ID: 22495388
[TBL] [Abstract][Full Text] [Related]
6. Neuropilin-1 is a receptor for extracellular miRNA and AGO2/miRNA complexes and mediates the internalization of miRNAs that modulate cell function.
Prud'homme GJ; Glinka Y; Lichner Z; Yousef GM
Oncotarget; 2016 Oct; 7(42):68057-68071. PubMed ID: 27486976
[TBL] [Abstract][Full Text] [Related]
7. Neuropilin-1 promotes Hedgehog signaling through a novel cytoplasmic motif.
Pinskey JM; Franks NE; McMellen AN; Giger RJ; Allen BL
J Biol Chem; 2017 Sep; 292(37):15192-15204. PubMed ID: 28667171
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer cell uptake of the inflammatory mediator neutrophil elastase triggers an anticancer adaptive immune response.
Mittendorf EA; Alatrash G; Qiao N; Wu Y; Sukhumalchandra P; St John LS; Philips AV; Xiao H; Zhang M; Ruisaard K; Clise-Dwyer K; Lu S; Molldrem JJ
Cancer Res; 2012 Jul; 72(13):3153-62. PubMed ID: 22564522
[TBL] [Abstract][Full Text] [Related]
9. The influence of neuropilin-1 silencing on semaphorin 3A and 3C activity in B16(F10) murine melanoma cells.
Mazurek AM; Olbryt M
Neoplasma; 2012; 59(1):43-51. PubMed ID: 22082309
[TBL] [Abstract][Full Text] [Related]
10. Neuropilin-1 is expressed by breast cancer stem-like cells and is linked to NF-κB activation and tumor sphere formation.
Glinka Y; Mohammed N; Subramaniam V; Jothy S; Prud'homme GJ
Biochem Biophys Res Commun; 2012 Sep; 425(4):775-80. PubMed ID: 22885184
[TBL] [Abstract][Full Text] [Related]
11. No functional and transductional significance of specific neuropilin 1 siRNA inhibition in colon carcinoma cell lines lacking VEGF receptor 2.
Quante M; Raskopf E; Stahl S; Vogt A; Sauerbruch T; Schmitz V
Oncol Rep; 2009 May; 21(5):1161-8. PubMed ID: 19360289
[TBL] [Abstract][Full Text] [Related]
12. Neuropilin-1 drives tumor-specific uptake of chlorotoxin.
McGonigle S; Majumder U; Kolber-Simonds D; Wu J; Hart A; Noland T; TenDyke K; Custar D; Li D; Du H; Postema MHD; Lai WG; Twine NC; Woodall-Jappe M; Nomoto K
Cell Commun Signal; 2019 Jun; 17(1):67. PubMed ID: 31208428
[TBL] [Abstract][Full Text] [Related]
13. Immunoglobulin Fc-Fused Peptide without C-Terminal Arg or Lys Residue Augments Neuropilin-1-Dependent Tumor Vascular Permeability.
Baek DS; Kim JH; Kim YJ; Kim YS
Mol Pharm; 2018 Feb; 15(2):394-402. PubMed ID: 29232521
[TBL] [Abstract][Full Text] [Related]
14. Neuropilin-1 Acts as a Receptor for Complement Split Products.
Battin C; De Sousa Linhares A; Paster W; Isenman DE; Wahrmann M; Leitner J; Zlabinger GJ; Steinberger P; Hofer J
Front Immunol; 2019; 10():2209. PubMed ID: 31572401
[TBL] [Abstract][Full Text] [Related]
15. Neuropilin-1-dependent regulation of EGF-receptor signaling.
Rizzolio S; Rabinowicz N; Rainero E; Lanzetti L; Serini G; Norman J; Neufeld G; Tamagnone L
Cancer Res; 2012 Nov; 72(22):5801-11. PubMed ID: 22986738
[TBL] [Abstract][Full Text] [Related]
16. HLA anchor optimization of the melan-A-HLA-A2 epitope within a long peptide is required for efficient cross-priming of human tumor-reactive T cells.
Chauvin JM; Larrieu P; Sarrabayrouse G; Prévost-Blondel A; Lengagne R; Desfrançois J; Labarrière N; Jotereau F
J Immunol; 2012 Mar; 188(5):2102-10. PubMed ID: 22291187
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of primary breast tumor growth and metastasis using a neuropilin-1 transmembrane domain interfering peptide.
Arpel A; Gamper C; Spenlé C; Fernandez A; Jacob L; Baumlin N; Laquerriere P; Orend G; Crémel G; Bagnard D
Oncotarget; 2016 Aug; 7(34):54723-54732. PubMed ID: 27351129
[TBL] [Abstract][Full Text] [Related]
18. Neuropilin-1 mediates vascular permeability independently of vascular endothelial growth factor receptor-2 activation.
Roth L; Prahst C; Ruckdeschel T; Savant S; Weström S; Fantin A; Riedel M; Héroult M; Ruhrberg C; Augustin HG
Sci Signal; 2016 Apr; 9(425):ra42. PubMed ID: 27117252
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of VEGF189 in breast cancer cells induces apoptosis via NRP1 under stress conditions.
Vintonenko N; Pelaez-Garavito I; Buteau-Lozano H; Toullec A; Lidereau R; Perret GY; Bieche I; Perrot-Applanat M
Cell Adh Migr; 2011; 5(4):332-43. PubMed ID: 21897119
[TBL] [Abstract][Full Text] [Related]
20. The Pro-Tumoral Activity of Heparan Sulfate 3-
Hellec C; Diawara M; Carpentier M; Denys A; Allain F
Molecules; 2018 Oct; 23(10):. PubMed ID: 30360368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
